Galectin Therapeutics (STU:PHPN) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:PHPN Galectin Therapeutics Inc STU:PHPN
22 GF Score
Price €4.68
! 5 Warning Signs
View Full Analysis

What is Galectin Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

STU:PHPN
22GF Score
Galectin Therapeutics Inc STU:PHPN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galectin Therapeutics Business Description

Other Exchanges GALT:USA
Address 4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA, USA, 30071
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
22GF Score

Get the complete analysis for STU:PHPN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.68
Price